Pantoprazole Sodium for Injection

Active Ingredients: Pantoprazole Sodium

Pantoprazole Sodium for Injection is used to treat conditions caused by excess stomach acid production. It relieves symptoms like heartburn and swallowing problems. Intravenous treatment is typically prescribed for patients with gastroesophageal reflux disease and a history of erosive esophagitis.

Pantoprazole is classified as a proton pump inhibitor (PPI). It works by blocking the production of acid, which reduces the amount of acid secreted into the stomach.

Pantoprazole Sodium for Injection is a GMP-certified product that has been manufactured by AdvaCare Pharma, This medication is a part of our extensive catalog of medical supplies available for global distribution. Our manufacturing facilities are located in China, India, and the USA.

AdvaCare Pharma, a US-owned pharmaceutical company, is a Pantoprazole for Injection manufacturer with GMP-compliant facilities located worldwide. We conduct periodic internal and third-party facility inspections to ensure that our products meet or surpass the requirements of our distributors. Our global reach extends to over 65 markets, where we supply a wide range of products to our partners, including distributors, hospitals, pharmacies, NGOs, and government institutions.

What is Pantoprazole Sodium for Injection used for?

How is Pantoprazole Sodium for Injection used?

Pantoprazole Sodium has been manufactured as a freeze-dried powder that is intended for reconstitution. It is intended to be mixed with the Saline (Sodium Chloride) and administered intravenously. Reconstituted solutions should be used immediately.

What dose should be given?

For non-erosive symptoms of GERD when oral treatment is unavailable, the usual dose is 20mg of Pantoprazole, given once per day by IV. The duration of treatment is 7-10 days.

Short-term treatment: for erosive esophagitis associated with GERD when oral treatment is unavailable, the usual dose is 40mg of Pantoprazole, given once per day by IV. The duration of treatment is 7-10 days.

Maintenance treatment: for erosive esophagitis associated with GERD when oral treatment is unavailable, the usual dose is 20-40mg of Pantoprazole, given once per day by IV. The duration of treatment is 7-10 days.

For hypersecretory conditions, the usual dose is 80mg of Pantoprazole, given every 12 hours by IV.

The exact dosage is based on the severity of the infections, age, gender, and weight. Refer to a doctor or pharmacist for guidelines.

As with all pharmaceuticals, some unwanted effects can occur from the use of Pantoprazole Sodium for Injection.

Consult a doctor or pharmacist for a comprehensive list of all side effects.

If any symptom persists or gets worse, or you notice any other symptoms, please call your doctor.

High-dose therapy or long-term usage of this drug should be avoided unless necessary.

As Pantoprazole decreases stomach acid, it may change how well certain medications work. Some known interactions include rilpivirine, nelfinavir, digoxin, methotrexate, diuretics, diazepam, warfarin, citalopram, phenytoin, and many more drugs. Consult with a doctor about any medications you are taking before your treatment.

Pantoprazole has not been proven safe for pediatric patients under the age of 5 years old.